Literature DB >> 25724887

Neurotoxin-induced DNA damage is persistent in SH-SY5Y cells and LC neurons.

Yan Wang1, Phillip R Musich, Kui Cui, Yue Zou, Meng-Yang Zhu.   

Abstract

Degeneration of the noradrenergic neurons has been reported in the brain of patients suffering from neurodegenerative diseases. However, their pathological characteristics during the neurodegenerative course and underlying mechanisms remain to be elucidated. In the present study, we used the neurotoxin camptothecin (CPT) to induce the DNA damage response in neuroblastoma SH-SY5Y cells, normal fibroblast cells, and primarily cultured locus coeruleus (LC) and raphe neurons to examine cellular responses and repair capabilities after neurotoxin exposure. To our knowledge, the present study is the first to show that noradrenergic SH-SY5Y cells are more sensitive to CPT-induced DNA damage and deficient in DNA repair, as compared to fibroblast cells. Furthermore, similar to SH-SY5Y cells, primarily cultured LC neurons are more sensitive to CPT-induced DNA damage and show a deficiency in repairing this damage. Moreover, while N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) exposure also results in DNA damage in cultured LC neurons, neither CPT nor DSP4 induce DNA damage in neuronal cultures from the raphe nuclei. Taken together, noradrenergic SH-SY5Y cells and LC neurons are sensitive to CPT-induced DNA damage and exhibit a repair deficiency, providing a mechanistic explanation for the pathological characteristics of LC degeneration when facing endogenous and environmental DNA-damaging insults in vivo.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25724887      PMCID: PMC4385397          DOI: 10.1007/s12640-015-9521-4

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  66 in total

1.  Effects of DSP4 on the noradrenergic phenotypes and its potential molecular mechanisms in SH-SY5Y cells.

Authors:  Yan Wang; Phillip R Musich; Moises A Serrano; Yue Zou; Jia Zhang; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2013-08-31       Impact factor: 3.911

Review 2.  Functional consequences of locus coeruleus degeneration in Alzheimer's disease.

Authors:  David Weinshenker
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 3.  Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases.

Authors:  Ivona Brasnjevic; Patrick R Hof; Harry W M Steinbusch; Christoph Schmitz
Journal:  DNA Repair (Amst)       Date:  2008-05-23

4.  Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.

Authors:  Guoxiang Liu; Jia Yu; Jinhui Ding; Chengsong Xie; Lixin Sun; Iakov Rudenko; Wang Zheng; Namratha Sastry; Jing Luo; Gay Rudow; Juan C Troncoso; Huaibin Cai
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

5.  Neurotoxic activity of a topoisomerase-I inhibitor, camptothecin, in cultured cerebellar granule neurons.

Authors:  M Uday Bhanu; Anand K Kondapi
Journal:  Neurotoxicology       Date:  2010-07-01       Impact factor: 4.294

6.  Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.

Authors:  J Srinivasan; Werner J Schmidt
Journal:  Behav Brain Res       Date:  2004-05-05       Impact factor: 3.332

7.  Noradrenergic denervation facilitates the release of acetylcholine and serotonin in the hippocampus: towards a mechanism underlying upregulations described in MCI patients?

Authors:  Rolf Jackisch; Simon Gansser; Jean-Christophe Cassel
Journal:  Exp Neurol       Date:  2008-06-24       Impact factor: 5.330

8.  Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion.

Authors:  Tommaso Cassano; Silvana Gaetani; Maria Grazia Morgese; Teresa Macheda; Leonardo Laconca; Pasqua Dipasquale; Juan Taltavull; Toni S Shippenberg; Vincenzo Cuomo; Gabriella Gobbi
Journal:  Neurochem Res       Date:  2009-02-20       Impact factor: 3.996

Review 9.  Noradrenergic mechanisms in neurodegenerative diseases: a theory.

Authors:  Marc R Marien; Francis C Colpaert; Alan C Rosenquist
Journal:  Brain Res Brain Res Rev       Date:  2004-04

10.  Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.

Authors:  Steven P Presgraves; Tariq Ahmed; Sabine Borwege; Jeffrey N Joyce
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.978

View more
  4 in total

1.  Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells.

Authors:  Yan Wang; Benjamin A Hilton; Kui Cui; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2015-06-03       Impact factor: 3.911

2.  Norepinephrine upregulates the expression of tyrosine hydroxylase and protects dopaminegic neurons against 6-hydrodopamine toxicity.

Authors:  Meng-Yang Zhu; Muhammad U Raza; Yanqiang Zhan; Yan Fan
Journal:  Neurochem Int       Date:  2019-09-17       Impact factor: 3.921

3.  Critical Role of Oxidatively Damaged DNA in Selective Noradrenergic Vulnerability.

Authors:  Yanqiang Zhan; Muhammad U Raza; Lian Yuan; Meng-Yang Zhu
Journal:  Neuroscience       Date:  2019-11-05       Impact factor: 3.708

4.  HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS.

Authors:  Elke Braems; Valérie Bercier; Evelien Van Schoor; Kara Heeren; Jimmy Beckers; Laura Fumagalli; Lieselot Dedeene; Matthieu Moisse; Ilse Geudens; Nicole Hersmus; Arpan R Mehta; Bhuvaneish T Selvaraj; Siddharthan Chandran; Ritchie Ho; Dietmar R Thal; Philip Van Damme; Bart Swinnen; Ludo Van Den Bosch
Journal:  Acta Neuropathol       Date:  2022-07-27       Impact factor: 15.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.